Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens.

Kirby S, Satoskar A, Brodsky S, Pope-Harman A, Nunley D, Hitchcock C, Pelletier R, Ross P, Nadasdy T, Shilo K.

Diagn Pathol. 2012 Mar 14;7:25. doi: 10.1186/1746-1596-7-25.

2.

Sirolimus-Induced Diffuse Alveolar Hemorrhage: A Case Report.

Balcan B, Simsek E, Ugurlu AO, Demiralay E, Sahin S.

Am J Ther. 2016 Nov/Dec;23(6):e1938-e1941.

PMID:
26849007
3.

Sirolimus-associated pulmonary toxicity.

Pham PT, Pham PC, Danovitch GM, Ross DJ, Gritsch HA, Kendrick EA, Singer J, Shah T, Wilkinson AH.

Transplantation. 2004 Apr 27;77(8):1215-20. Review.

PMID:
15114088
4.

Patterns of pulmonary complications associated with sirolimus.

Chhajed PN, Dickenmann M, Bubendorf L, Mayr M, Steiger J, Tamm M.

Respiration. 2006;73(3):367-74. Epub 2005 Aug 25.

PMID:
16127266
5.

Mycobacterium xenopi pulmonary infection in two renal transplant recipients under sirolimus therapy.

Thaunat O, Morelon E, Stern M, Buffet P, Offredo C, Mamzer-Bruneel MF, Kreis H.

Transpl Infect Dis. 2004 Dec;6(4):179-82.

PMID:
15762936
6.

Sirolimus-associated diffuse alveolar hemorrhage.

Vlahakis NE, Rickman OB, Morgenthaler T.

Mayo Clin Proc. 2004 Apr;79(4):541-5. Review.

PMID:
15065619
7.

Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.

Sayin B, Karakayali H, Colak T, Sevmis S, Pehlivan S, Demirhan B, Haberal M.

Transplant Proc. 2009 Sep;41(7):2789-93. doi: 10.1016/j.transproceed.2009.07.094.

PMID:
19765436
8.
9.

Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.

Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.

Nephrol Dial Transplant. 2005 Nov;20(11):2517-23. Epub 2005 Jun 28.

PMID:
15985508
10.

Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients.

Kahan BD, Yakupoglu YK, Schoenberg L, Knight RJ, Katz SM, Lai D, Van Buren CT.

Transplantation. 2005 Sep 27;80(6):749-58.

PMID:
16210961
11.

Sirolimus-associated diffuse alveolar hemorrhage in a renal transplant recipient on long-term anticoagulation.

Hashemi-Sadraei N, Sadrpour S, Baram D, Miller F, Nord EP.

Clin Nephrol. 2007 Oct;68(4):238-44.

PMID:
17969492
12.

Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus.

de Sandes-Freitas TV, Felipe CR, Campos ÉF, de Lima MG, Soares MF, de Franco MF, Aguiar WF, Tedesco-Silva H, Medina-Pestana JO.

Transplantation. 2015 Nov;99(11):2372-81. doi: 10.1097/TP.0000000000000748.

PMID:
25929604
13.

Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.

Garrean S, Massad MG, Tshibaka M, Hanhan Z, Caines AE, Benedetti E.

Clin Transplant. 2005 Oct;19(5):698-703.

PMID:
16146565
14.

Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus.

Kadikoy H, Paolini M, Achkar K, Suki W, Gaber AO, Anwar N, Jeroudi A, Barrios R, Abdellatif A.

Nephrol Dial Transplant. 2010 Aug;25(8):2795-8. doi: 10.1093/ndt/gfq265. Epub 2010 May 19. Review.

PMID:
20484303
15.

Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients.

Morelon E, Stern M, Israël-Biet D, Correas JM, Danel C, Mamzer-Bruneel MF, Peraldi MN, Kreis H.

Transplantation. 2001 Sep 15;72(5):787-90.

PMID:
11571438
16.

[Pulmonary toxicity associated with sirolimus therapy in liver transplantation].

Jiménez Pérez M, Olmedo Martín R, Marín García D, Lozano Rey JM, de la Cruz Lombardo J, Rodrigo López JM.

Gastroenterol Hepatol. 2006 Dec;29(10):616-8. Review. Spanish.

PMID:
17198638
17.

Cavitatory lung disease in thoracic transplant recipients receiving sirolimus.

Banerjee SK, Santhanakrishnan K, Tsui S, Parameshwar J, Parmar J.

J Heart Lung Transplant. 2012 May;31(5):548-51. doi: 10.1016/j.healun.2012.02.010. Epub 2012 Mar 6.

PMID:
22397867
18.

Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.

Stephany BR, Boumitri M, Budev M, Alao B, Poggio ED.

J Heart Lung Transplant. 2009 Jun;28(6):564-71. doi: 10.1016/j.healun.2009.03.010.

PMID:
19481016
19.

A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk.

Lee J, Lee JJ, Kim BS, Lee JG, Huh KH, Park Y, Kim YS.

J Korean Med Sci. 2015 Jun;30(6):682-7. doi: 10.3346/jkms.2015.30.6.682. Epub 2015 May 13.

20.

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.

Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP; Sirolimus Renal Function Study Group.

Transplantation. 2002 Dec 15;74(11):1560-7.

PMID:
12490789

Supplemental Content

Support Center